hexamethonium has been researched along with Pancreatic Diseases in 3 studies
Hexamethonium: A nicotinic cholinergic antagonist often referred to as the prototypical ganglionic blocker. It is poorly absorbed from the gastrointestinal tract and does not cross the blood-brain barrier. It has been used for a variety of therapeutic purposes including hypertension but, like the other ganglionic blockers, it has been replaced by more specific drugs for most purposes, although it is widely used a research tool.
Pancreatic Diseases: Pathological processes of the PANCREAS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| BILLINGTON, BP | 1 |
| PATON, A | 1 |
| REYNOLDS, TB | 1 |
| SHERLOCK, S | 1 |
| MARLEY, E | 1 |
| LAURENCE, DR | 1 |
| STACEY, RS | 1 |
3 other studies available for hexamethonium and Pancreatic Diseases
| Article | Year |
|---|---|
The effect of hexamethonium bromide on the circulatory and metabolic response to insulin hypoglycemia in man.
Topics: Hexamethonium; Humans; Hypoglycemia; Insulin; Male; Muscle Relaxants, Central; Pancreatic Diseases | 1954 |
Modification of hypoglycaemia with hexamethonium bromide.
Topics: Hexamethonium; Hexamethonium Compounds; Humans; Hypoglycemia; Insulin; Pancreatic Diseases | 1957 |
Effect of hexamethonium on the response to insulin in animals and man.
Topics: Animals; Cardiovascular Agents; Hexamethonium; Humans; Hypoglycemia; Insulin; Male; Muscle Relaxants | 1952 |